Pomalidomide (Pomalyst)

Epidemiology

  • Indications
    • Multiple Myeloma

Adverse Effects

Pulmonary Manifestations


References

  • Acute Lung Toxicity Related to Pomalidomide. Chest August 2011 vol. 140 no. 2 529-533